1. Home
  2. MRSN vs ZDGE Comparison

MRSN vs ZDGE Comparison

Compare MRSN & ZDGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • ZDGE
  • Stock Information
  • Founded
  • MRSN 2001
  • ZDGE 2008
  • Country
  • MRSN United States
  • ZDGE United States
  • Employees
  • MRSN N/A
  • ZDGE N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • ZDGE Computer Software: Prepackaged Software
  • Sector
  • MRSN Health Care
  • ZDGE Technology
  • Exchange
  • MRSN Nasdaq
  • ZDGE Nasdaq
  • Market Cap
  • MRSN 40.7M
  • ZDGE 40.3M
  • IPO Year
  • MRSN 2017
  • ZDGE N/A
  • Fundamental
  • Price
  • MRSN $0.37
  • ZDGE $2.43
  • Analyst Decision
  • MRSN Strong Buy
  • ZDGE
  • Analyst Count
  • MRSN 5
  • ZDGE 0
  • Target Price
  • MRSN $5.75
  • ZDGE N/A
  • AVG Volume (30 Days)
  • MRSN 3.1M
  • ZDGE 25.9K
  • Earning Date
  • MRSN 05-15-2025
  • ZDGE 06-12-2025
  • Dividend Yield
  • MRSN N/A
  • ZDGE N/A
  • EPS Growth
  • MRSN N/A
  • ZDGE N/A
  • EPS
  • MRSN N/A
  • ZDGE N/A
  • Revenue
  • MRSN $34,006,000.00
  • ZDGE $29,412,000.00
  • Revenue This Year
  • MRSN N/A
  • ZDGE N/A
  • Revenue Next Year
  • MRSN N/A
  • ZDGE $1.07
  • P/E Ratio
  • MRSN N/A
  • ZDGE N/A
  • Revenue Growth
  • MRSN N/A
  • ZDGE 4.26
  • 52 Week Low
  • MRSN $0.26
  • ZDGE $1.73
  • 52 Week High
  • MRSN $2.83
  • ZDGE $4.38
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 51.71
  • ZDGE 55.32
  • Support Level
  • MRSN $0.33
  • ZDGE $2.12
  • Resistance Level
  • MRSN $0.38
  • ZDGE $2.50
  • Average True Range (ATR)
  • MRSN 0.04
  • ZDGE 0.13
  • MACD
  • MRSN 0.00
  • ZDGE 0.01
  • Stochastic Oscillator
  • MRSN 58.60
  • ZDGE 75.61

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About ZDGE Zedge Inc. Class B

Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.

Share on Social Networks: